Drugs / Dexrabeprazole
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02689999 | Feb 2016 → May 2017 | gastroesophageal reflux disease | Neutec Ar-Ge San ve Tic A.Ş | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dexrabeprazole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02689999 ↗ |
| Modality | Small molecule | — CHEMBL1615209 ↗ |